idelalisib and Neoplasm-Metastasis

idelalisib has been researched along with Neoplasm-Metastasis* in 1 studies

Other Studies

1 other study(ies) available for idelalisib and Neoplasm-Metastasis

Article	Year
Idelalisib Rescues Natural Killer Cells from Monocyte-Induced Immunosuppression by Inhibiting NOX2-Derived Reactive Oxygen Species. Cancer immunology research, 2020, Volume: 8, Issue:12 Topics: Animals; Antigens, CD20; Antineoplastic Agents; Humans; Immunosuppression Therapy; Killer Cells, Natural; Leukemia, Lymphocytic, Chronic, B-Cell; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Knockout; Monocytes; NADPH Oxidase 2; Neoplasm Metastasis; Phosphoinositide-3 Kinase Inhibitors; Purines; Quinazolinones; Reactive Oxygen Species	2020

Article

Year

Idelalisib Rescues Natural Killer Cells from Monocyte-Induced Immunosuppression by Inhibiting NOX2-Derived Reactive Oxygen Species.

Cancer immunology research, 2020, Volume: 8, Issue:12

Topics: Animals; Antigens, CD20; Antineoplastic Agents; Humans; Immunosuppression Therapy; Killer Cells, Natural; Leukemia, Lymphocytic, Chronic, B-Cell; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Knockout; Monocytes; NADPH Oxidase 2; Neoplasm Metastasis; Phosphoinositide-3 Kinase Inhibitors; Purines; Quinazolinones; Reactive Oxygen Species

2020